ATE554392T1 - Diagnoseverfahren für sprue/zöliakie - Google Patents
Diagnoseverfahren für sprue/zöliakieInfo
- Publication number
- ATE554392T1 ATE554392T1 AT03789958T AT03789958T ATE554392T1 AT E554392 T1 ATE554392 T1 AT E554392T1 AT 03789958 T AT03789958 T AT 03789958T AT 03789958 T AT03789958 T AT 03789958T AT E554392 T1 ATE554392 T1 AT E554392T1
- Authority
- AT
- Austria
- Prior art keywords
- sprue
- celiac disease
- diagnostic procedure
- digestion
- refractory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42803302P | 2002-11-20 | 2002-11-20 | |
PCT/US2003/037434 WO2004045392A2 (en) | 2002-11-20 | 2003-11-20 | Diagnostic method for celiac sprue |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE554392T1 true ATE554392T1 (de) | 2012-05-15 |
Family
ID=32326628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03789958T ATE554392T1 (de) | 2002-11-20 | 2003-11-20 | Diagnoseverfahren für sprue/zöliakie |
Country Status (8)
Country | Link |
---|---|
US (3) | US7776545B2 (de) |
EP (1) | EP1563300B1 (de) |
AT (1) | ATE554392T1 (de) |
AU (1) | AU2003294473A1 (de) |
CA (1) | CA2502700C (de) |
DK (1) | DK1563300T3 (de) |
ES (1) | ES2383595T3 (de) |
WO (1) | WO2004045392A2 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9923306D0 (en) * | 1999-10-01 | 1999-12-08 | Isis Innovation | Diagnostic and therapeutic epitope, and transgenic plant |
US7780961B2 (en) | 2001-05-03 | 2010-08-24 | Actogenix N.V. | Self-containing Lactococcus strain |
US8143210B2 (en) * | 2002-02-14 | 2012-03-27 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
DK1572127T4 (da) | 2002-02-14 | 2014-11-24 | Univ Leland Stanford Junior | Enzymbehandling af fødevarer til cøliaki |
US7202216B2 (en) * | 2002-05-14 | 2007-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for celiac sprue |
US7265093B2 (en) * | 2002-05-14 | 2007-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for Celiac Sprue |
US7462688B2 (en) * | 2002-05-14 | 2008-12-09 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for diagnostic and therapeutic methods for celiac sprue |
WO2003096979A2 (en) * | 2002-05-14 | 2003-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for celiac sprue |
GB0212885D0 (en) * | 2002-06-05 | 2002-07-17 | Isis Innovation | Therapeutic epitopes and uses thereof |
DK1563300T3 (da) | 2002-11-20 | 2012-07-23 | Univ Leland Stanford Junior | Diagnostisk fremgangsmåde til cøliaki |
US7579313B2 (en) * | 2003-11-18 | 2009-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
US10105437B2 (en) * | 2004-04-28 | 2018-10-23 | Btg International Limited | Epitopes related to coeliac disease |
EP2486934A1 (de) * | 2004-04-28 | 2012-08-15 | BTG International Limited | Epitope im Zusammenhang mit Zöliakie |
AU2011247868B2 (en) * | 2004-04-28 | 2014-05-22 | Btg International Limited | Epitopes related to coeliac disease |
US8748126B2 (en) | 2005-11-29 | 2014-06-10 | Actogenix N.V. | Induction of mucosal tolerance to antigens |
BRPI0807857A2 (pt) | 2007-01-25 | 2014-05-27 | Actogenix Nv | Tratamento de doença imune por meio de distribuição através da mucosa de antígenos. |
US8148105B2 (en) * | 2007-03-16 | 2012-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Scaleable manufacturing process for cysteine endoprotease B, isoform 2 |
EP2136833B1 (de) | 2007-03-16 | 2019-05-01 | The Board of Trustees of the Leland Stanford Junior University | Kombinationsenzymtherapie zum aufschluss von gluten in der nahrung |
WO2009131909A2 (en) * | 2008-04-21 | 2009-10-29 | Bio-Rad Laboratories, Inc. | Recombinant deamidated gliadin antigen |
US8835603B2 (en) | 2008-11-30 | 2014-09-16 | Immusant, Inc. | Agents for the treatment of celiac disease |
HU0900199D0 (en) * | 2009-04-01 | 2009-06-29 | Debreceni Egyetem | Diagnosis of gluten-induced autoimmune diseases |
HU0900195D0 (en) * | 2009-04-01 | 2009-06-29 | Debreceni Egyetem | Diagnosis and treatment of gluten-induced autoimmune diseases |
US20120107847A1 (en) * | 2009-07-02 | 2012-05-03 | Dsm Ip Assets B.V. | Testing efficacy for celiac disease |
DE102009045268A1 (de) * | 2009-10-01 | 2011-04-07 | Charité - Universitätsmedizin Berlin | Neue Marker für die Diagnose von Zöliakie |
US8685392B2 (en) | 2009-10-07 | 2014-04-01 | Trustees Of Boston University | Rothia species glutamine endopeptidases and use thereof |
US20110200574A1 (en) | 2010-02-02 | 2011-08-18 | Jolly James F | Use of proteases for gluten intolerance |
WO2012006384A2 (en) | 2010-07-07 | 2012-01-12 | Trustees Of Boston University | Rothia species gluten-degrading enzymes and uses thereof |
ES2385455B2 (es) * | 2010-12-28 | 2013-09-25 | Universidad De Sevilla | Determinación de niveles de péptidos inmunogénicos del gluten en muestras humanas. |
EP4023243A3 (de) | 2011-08-10 | 2022-09-14 | University of Washington through its Center for Commercialization | Zusammensetzungen und verfahren zur behandlung von zöliakie/sprue |
ES2402286B1 (es) * | 2011-09-29 | 2014-03-04 | Universidad De Valladolid | Péptido inmunogénico del gluten y sus aplicaciones. |
JP6148250B2 (ja) * | 2011-12-05 | 2017-06-14 | バイオ−ラッド ラボラトリーズ,インコーポレイティド | 組換え脱アミド化グリアジン抗原 |
JP6517204B2 (ja) | 2013-08-14 | 2019-05-22 | ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャリゼーション | セリアックスプルー病を処置するための組成物および方法 |
EP3043812A1 (de) | 2013-09-10 | 2016-07-20 | Immusant Inc. | Dosierung einer glutenpeptidzusammensetzung |
EP3134737A4 (de) * | 2014-04-24 | 2018-01-17 | Immusant Inc. | Verfahren zur diagnose und behandlung von zöliakie bei kindern |
ES2556177B1 (es) * | 2014-07-09 | 2016-10-20 | Universidad De Sevilla | Detección de péptidos del gluten en fluidos humanos |
WO2016054038A1 (en) | 2014-09-29 | 2016-04-07 | Immusant, Inc. | Use of hla genetic status to assess or select treatment of celiac disease |
EP3302518A1 (de) | 2015-06-08 | 2018-04-11 | University of Washington | Zusammensetzungen und verfahren zur behandlung von zöliakie/sprue |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7414128A (nl) | 1973-10-31 | 1975-05-02 | James Joseph Phelan | Werkwijze voor de detoxificatie van gluten. |
US4203967A (en) * | 1977-01-13 | 1980-05-20 | Hoffmann-La Roche Inc. | Diagnostic test for malabsorption |
US4562003A (en) * | 1984-10-26 | 1985-12-31 | California Biotechnology, Inc. | Monoclonal antibodies against alveolar surfactant protein |
US4912120A (en) * | 1986-03-14 | 1990-03-27 | Syntex (U.S.A.) Inc. | 3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors |
US4929630A (en) * | 1986-03-14 | 1990-05-29 | Syntex (U.S.A.) Inc. | Transglutaminase inhibitors |
IL81887A0 (en) | 1986-03-14 | 1987-10-20 | Syntex Inc | Dihydroisoxazole derivatives,their preparation and pharmaceutical compositions containing them |
DD262999A1 (de) | 1987-07-27 | 1988-12-21 | Adw Ddr | Verfahren zur herstellung eines diaetetikums fuer zoeliakie- und spruekranke |
US5208021A (en) | 1987-10-05 | 1993-05-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of preparing diphtheria immunotoxins |
US5372933A (en) | 1988-10-03 | 1994-12-13 | The Scripps Research Institute | Polypeptides that mimic receptor-induced binding sites, and methods of using same |
US5766897A (en) | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
US5811098A (en) | 1992-11-24 | 1998-09-22 | Bristol-Myers Squibb Company | Antibodies to HER4, human receptor tyrosine kinase |
GB9225021D0 (en) | 1992-11-30 | 1993-01-20 | Sandoz Ltd | Organic compounds |
WO1994026774A1 (en) | 1993-05-19 | 1994-11-24 | Cytel Corporation | Novel treatments for allergic diseases |
US6197356B1 (en) * | 1993-08-03 | 2001-03-06 | Immunopath Profile, Inc. | Process for preparing hypoallergenic foods |
US5663304A (en) | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
AU1739395A (en) | 1994-02-07 | 1995-08-21 | United States Of America, As Represented By The Secretary Of Agriculture, The | Detection of wheat that has experienced elevated temperatures during the grain filling period |
EP0783517A2 (de) | 1994-09-29 | 1997-07-16 | Merck & Co. Inc. | Inhibitoren der farnesyl-transferase |
US5834428A (en) * | 1995-04-14 | 1998-11-10 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
GB9509336D0 (en) | 1995-05-09 | 1995-06-28 | Dynal As | Chemical method |
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US20020018763A1 (en) | 1995-05-24 | 2002-02-14 | Kriszkina M. Zsebo | A method of stimulating growth of stromal cells with stem cell factor (scf) polypeptides |
DE19630557C2 (de) * | 1996-07-18 | 1998-07-02 | Schuppan Detlef Priv Doz Dr Dr | Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie |
US7696338B2 (en) | 1995-10-30 | 2010-04-13 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxin fusion proteins and means for expression thereof |
US5716794A (en) * | 1996-03-29 | 1998-02-10 | Xybernaut Corporation | Celiac antigen |
EP0821238B1 (de) * | 1996-07-24 | 2003-07-02 | Antonio Picarelli | Verfahren und Testsatz zur in vitro Bestätigung der Diagnose von Bauchkrankheit |
US5912327A (en) | 1996-09-30 | 1999-06-15 | Human Genome Sciences, Inc. | Method of purifying chemokines from inclusion bodies |
US6635462B1 (en) | 1997-05-12 | 2003-10-21 | Phoenix Pharmacologies, Inc. | Mutated form of arginine deiminase |
EP0905518A1 (de) | 1997-09-23 | 1999-03-31 | Academisch Ziekenhuis Leiden | Peptiden spezifisch für Glutenempfindliche T-Zellen und Verwendung davon |
US20020052026A1 (en) | 1997-10-08 | 2002-05-02 | Steven M. Vicik | Methods of refolding proteins |
EA003190B1 (ru) * | 1997-12-31 | 2003-02-27 | Пфайзер Продактс Инк. | Азаполициклические соединения, конденсированные с арилом |
WO1999056698A2 (en) * | 1998-05-06 | 1999-11-11 | Københavns Universitet | Treatment of celiac disease |
US6201695B1 (en) | 1998-10-26 | 2001-03-13 | Micron Technology, Inc. | Heat sink for chip stacking applications |
AU3110500A (en) * | 1998-12-04 | 2000-06-19 | Barnes-Jewish Hospital | Cell matrix plaques of initial bone formation |
ATE494388T1 (de) | 1999-01-13 | 2011-01-15 | Univ New York State Res Found | Neues verfahren zum erschaffen von proteinkinase- inhibitoren |
GB9912350D0 (en) | 1999-05-26 | 1999-07-28 | European Molecular Biology Lab Embl | Modified cytokine |
US6962989B1 (en) | 1999-07-08 | 2005-11-08 | Basf Aktiengesellschaft | Corynebacterium glutamicum genes encoding novel proteins |
US6395889B1 (en) | 1999-09-09 | 2002-05-28 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding human protease homologs |
GB9923306D0 (en) * | 1999-10-01 | 1999-12-08 | Isis Innovation | Diagnostic and therapeutic epitope, and transgenic plant |
WO2001029078A2 (en) | 1999-10-15 | 2001-04-26 | Heska Corporation | Method for production and use of mite group 1 proteins |
US6492498B1 (en) | 1999-11-15 | 2002-12-10 | Regents Of The University Of Minnesota | Multimeric immunotoxins |
US6667160B2 (en) * | 2000-03-15 | 2003-12-23 | Kenneth D. Fine | Method for diagnosing immunologic food sensitivity |
US6642036B2 (en) | 2000-07-07 | 2003-11-04 | E. I. Du Pont De Nemours And Company | Sinapoylglucose:malate sinapoyltransferase form malate conjugates from benozic acid glucosides |
US6833447B1 (en) | 2000-07-10 | 2004-12-21 | Monsanto Technology, Llc | Myxococcus xanthus genome sequences and uses thereof |
EP1201136A1 (de) | 2000-10-31 | 2002-05-02 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Transglutaminasehemmer mit Nahrungsmittelqualitität und Verwendungen davon |
DE60132801T2 (de) * | 2000-12-07 | 2009-02-12 | Dsm Ip Assets B.V. | Prolylendoprotease aus aspergillus niger |
CA2706364A1 (en) | 2000-12-07 | 2002-06-13 | Dsm Ip Assets B.V. | Method for the prevention or reduction of haze in beverages |
EP1360192A1 (de) | 2001-01-16 | 2003-11-12 | Kobenhavns Universitet | Verfahren zur zurückfaltung von proteinen |
US7442370B2 (en) | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
MXPA03009313A (es) | 2001-04-12 | 2004-11-12 | Academish Ziekenhuis Leiden | Metodos y medios para uso de receptores de celulas t restringidos por hla-dq y peptidos derivados de prolamina unidos a hla-dq. |
US6645739B2 (en) | 2001-07-26 | 2003-11-11 | Phoenix Pharmacologies, Inc. | Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same |
NO20015814D0 (no) | 2001-11-28 | 2001-11-28 | Amersham Health As | Metallkompleksforbindelser |
EP1332760A1 (de) | 2002-02-04 | 2003-08-06 | Academisch Ziekenhuis Leiden | Neue Epitope für Zöliakie und Autoimmunerkrankungen, Methoden zu deren Detektion und neue nichtantigene Futterzusätze |
DK1572127T4 (da) * | 2002-02-14 | 2014-11-24 | Univ Leland Stanford Junior | Enzymbehandling af fødevarer til cøliaki |
US7320788B2 (en) | 2002-02-14 | 2008-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for Celiac Sprue |
US20030224476A1 (en) | 2002-03-01 | 2003-12-04 | Szu-Yi Chou | Method of producing transglutaminase reactive compound |
US7202216B2 (en) * | 2002-05-14 | 2007-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for celiac sprue |
US7462688B2 (en) * | 2002-05-14 | 2008-12-09 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for diagnostic and therapeutic methods for celiac sprue |
WO2003096979A2 (en) | 2002-05-14 | 2003-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for celiac sprue |
US7265093B2 (en) | 2002-05-14 | 2007-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for Celiac Sprue |
US6903246B2 (en) | 2002-05-28 | 2005-06-07 | The Regents Of The University Of California | Dehydroascorbate reductase (“DHAR”) genes from Triticum aestivum and their use to modulate ascorbic acid levels in plants |
GB0212885D0 (en) * | 2002-06-05 | 2002-07-17 | Isis Innovation | Therapeutic epitopes and uses thereof |
DK1563300T3 (da) | 2002-11-20 | 2012-07-23 | Univ Leland Stanford Junior | Diagnostisk fremgangsmåde til cøliaki |
CN1311076C (zh) | 2003-04-16 | 2007-04-18 | 普罗特奥姆技术公司 | 生产重组尿激酶的方法 |
US20050049064A1 (en) | 2003-09-02 | 2005-03-03 | Gagne Robert M. | Golf training apparatus |
US7579313B2 (en) * | 2003-11-18 | 2009-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
WO2005058930A2 (en) | 2003-12-11 | 2005-06-30 | Proteomtech Inc. | Methods for production of recombinant vascular endothelial cell growth inhibitor |
US7534426B2 (en) | 2004-04-26 | 2009-05-19 | The Board Of Trustees Of The Leland Stanford Junior University | Glutenase enzyme assays |
US7521427B2 (en) | 2004-11-09 | 2009-04-21 | Georgia Tech Research Corporation | Peptidyl allyl sulfones |
WO2007044906A2 (en) | 2005-10-11 | 2007-04-19 | Alvine Pharmaceuticals, Inc. | Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides |
WO2007047303A2 (en) | 2005-10-12 | 2007-04-26 | Alvine Pharmaceuticals, Inc. | Pegylated glutenase polypeptides |
US20090220554A1 (en) | 2005-10-25 | 2009-09-03 | John Griffin | Transglutaminase Inhibitors and Methods of Use Thereof |
US20070099238A1 (en) | 2005-10-31 | 2007-05-03 | Sigalas Mihail M | Enhancement of emission using metal coated dielectric nanoparticles |
EP1845103B1 (de) | 2006-04-10 | 2015-02-25 | Boehringer Ingelheim RCV GmbH & Co KG | Verfahren zur Proteinfaltung |
US8148105B2 (en) | 2007-03-16 | 2012-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Scaleable manufacturing process for cysteine endoprotease B, isoform 2 |
EP2136833B1 (de) | 2007-03-16 | 2019-05-01 | The Board of Trustees of the Leland Stanford Junior University | Kombinationsenzymtherapie zum aufschluss von gluten in der nahrung |
JP2012500263A (ja) | 2008-08-21 | 2012-01-05 | アルヴィン ファーマシューティカルズ インコーポレーティッド | タンパク質の経口投与のための製剤 |
NZ591940A (en) | 2008-10-10 | 2013-08-30 | Alvine Pharmaceuticals Inc | Dosage forms that facilitate rapid activation of zymogen |
-
2003
- 2003-11-20 DK DK03789958.0T patent/DK1563300T3/da active
- 2003-11-20 CA CA2502700A patent/CA2502700C/en not_active Expired - Lifetime
- 2003-11-20 AT AT03789958T patent/ATE554392T1/de active
- 2003-11-20 WO PCT/US2003/037434 patent/WO2004045392A2/en not_active Application Discontinuation
- 2003-11-20 US US10/531,547 patent/US7776545B2/en active Active
- 2003-11-20 AU AU2003294473A patent/AU2003294473A1/en not_active Abandoned
- 2003-11-20 ES ES03789958T patent/ES2383595T3/es not_active Expired - Lifetime
- 2003-11-20 EP EP03789958A patent/EP1563300B1/de not_active Expired - Lifetime
-
2010
- 2010-07-19 US US12/839,278 patent/US8071316B2/en not_active Expired - Fee Related
-
2011
- 2011-11-04 US US13/289,905 patent/US8426145B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20120083004A1 (en) | 2012-04-05 |
EP1563300A4 (de) | 2010-08-11 |
WO2004045392A3 (en) | 2004-08-26 |
US8426145B2 (en) | 2013-04-23 |
US20060240475A1 (en) | 2006-10-26 |
AU2003294473A1 (en) | 2004-06-15 |
AU2003294473A8 (en) | 2004-06-15 |
DK1563300T3 (da) | 2012-07-23 |
CA2502700A1 (en) | 2004-06-03 |
US20100317025A1 (en) | 2010-12-16 |
ES2383595T3 (es) | 2012-06-22 |
CA2502700C (en) | 2017-01-17 |
EP1563300A2 (de) | 2005-08-17 |
EP1563300B1 (de) | 2012-04-18 |
WO2004045392A2 (en) | 2004-06-03 |
US7776545B2 (en) | 2010-08-17 |
US8071316B2 (en) | 2011-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE554392T1 (de) | Diagnoseverfahren für sprue/zöliakie | |
ATE470391T1 (de) | System für die probenahme und analyse in vivo | |
WO2008028489A3 (en) | Ip-i0 based immunological monitoring | |
BRPI0618713B8 (pt) | cardiolipina modificada e seus usos | |
WO2008089072A3 (en) | Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring | |
WO2007002579A3 (en) | Assay cartridges and methods for point of care instruments | |
TR200003903T2 (tr) | Karsinomların erken teşhisi için yöntem | |
ATE490465T1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
WO2005013666A3 (en) | Novel translocation assay | |
NO20051024L (no) | Fremgangsmate for diagnostisering av multippel sklerose | |
HUP0203691A2 (hu) | Nemhagyományos transzmisszibilis ágens biológiai mintabeli jelenlétének kimutatásán alapuló eljárás szubakut transzmisszibilis spongiform encephalopathia diagnózisára | |
WO2006023312A3 (en) | Diagnostic assay for source of inflammation | |
EA200970244A1 (ru) | Медицинский прибор | |
SG170051A1 (en) | T cell assays | |
ATE474228T1 (de) | Reagenz für hämoglobinabbau | |
EP1774327A4 (de) | Verfahren und kits zur messung von adamts13/fxi-komplexen | |
ATE513851T1 (de) | Menschliches gen zur fruchtbarkeit entscheidend | |
WO2007000169A3 (en) | Non-human mammalian arthritis model featuring human antibodies against citrullinated proteins | |
WO2007149486A3 (en) | Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components | |
ATE271225T1 (de) | Verwendung von urintrypsininhibitor zur diagnose von aids | |
CA2407760A1 (en) | Methods for diagnosis of low grade astrocytoma | |
DE502006004301D1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum | |
DE60229513D1 (de) | Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten | |
ATE500275T1 (de) | Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten | |
EP1636587A4 (de) | Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose |